BiotechWilson

Brian Wilson

BiotechWilson’s Activity

Tue Jul 22

NL

Article

BiotechWilson published an article 5:00 PM

Why Investors Continue to Flee Aegerion Stock

In theory Aegerion could still reach this peaks sales figure (quite easily) given that there are many more reimbursable HoFH patients out there, but it appears that Amgen’s (AMGN) hugely successful PCSK9 inhibitor evolocumab will dethrone Juxtapid [more]

Tue Jul 15

NL

Article

BiotechWilson published an article 5:00 PM

Ariad Stock's Biggest Risk Is Its Only Hope

f Ariad continued to see high rates of Iclusig-induced serious adverse events and/or deaths amongst cancer patients in its new trials, the stock could be in serious trouble.

Mon Jul 14

NL

Article

BiotechWilson published an article 6:04 PM

Up 33%: Is Vertex Pharmaceuticals Stock Overpriced?

Read below for more on this stock, which has climbed so much year-to-date and seems to potentially be priced to perfection.

Tue Jul 8

NL

Article

BiotechWilson published an article 2:01 PM

Is This the Crown Jewel of the ISIS Pipeline?

Perhaps the most promising target in the ISIS pipeline is ApoCIII – a protein that is responsible for transporting triglycerides in the blood.

Mon Jun 30

NL

Article

BiotechWilson published an article 11:41 AM

Why Teva's Magic Bullet Could Misfire

But with the recent loss of its lawsuit against the FDA's approval of these generic (which was meant to block competing glatiramer acetate formulations without additional bioequivalency trial data) it’s clear that the new 40 mg/mL formulation of [more]

Fri Jun 27

NL

Article

BiotechWilson published an article 4:25 PM

Why I'm Still Avoiding Questcor

A total of seven litigations against Questcor are currently underway. Two of them - the Retrophin litigation and USAO litigation - represent very serious threats to the H.P. Acthar business model.

Thu Jun 26

NL

Article

BiotechWilson published an article 9:00 AM

Will Amgen’s Acquisition of Onyx Pay off Soon?

Perhaps the most important part of the Onyx acquisition was Kyprolis – a blood cancer drug that is currently being marketed as a last resort option for multiple myeloma patients.

Tue Jun 24

NL

Watercooler Post

BiotechWilson wrote 4:59 PM

The official Northwest Biotherapeutics theme song: https://www.youtube.com/watch?v=-WCFUGCOLLU

Mon Jun 23

NL

Article

BiotechWilson published an article 5:30 PM

Bristol-Myers Squibb's Oncology Opportunity

But despite all the challenging facing Bristol-Myers today, I do believe the positioned to do extremely well in oncology due to the commercial potential of Sprycel (dasatinib) and Yervoy (ipilimumab). Both drugs have been growing sales rapidly [more]

NL

Article

BiotechWilson published an article 4:42 PM

Exceptional Growth in the Research Supply Industry

If we go all the way back to 1994, we can see that SIAL and TMO appreciated by 905% and 620% - beating the 343% returns seen on the S&P 500.

Thu Jun 19

NL

Article

BiotechWilson published an article 11:37 PM

Pharma’s Huge Bet on Immunotherapies

Given the data that have been released so far, it appears that the discovery of the PD-1/PD-L1 mechanism is the single biggest technological leap in the immunotherapy space to date.

Wed Jun 18

NL

Watercooler Post

BiotechWilson wrote 10:07 AM

ECYT has been punished enough for the failure of its partnership with Merck, we're probably going to see some consolidation now. But there is no reason for a recovery rally either.

Tue Jun 17

NL

Article

BiotechWilson published an article 10:42 AM

Why This "Worst Deal" Could Work

Merck has been taking heat for the price it paid for Idenix -- Here's why it actually isn't as crazy as it sounds.

CAPS Stats & Trivia

CAPS Player Rating < 20
Player Rank 0 out of 69331
Score 0.00
Score Change Today +30.32
Accuracy 0.00%
Active Picks 0
Total Picks 13
Best Pick NWBO (+29.03)
Worst Pick SRPT (-15.90)
Average Score per Pick 3.53
Charms Earned 0
Highest Rated Favorite No Favorites Selected
Go to BiotechWilson’s CAPS page

Boards Stats & Trivia

Board Posts 0
Recs Received 0
People who have rec'd these posts 0
Recs to Posts Ratio (last 30 days) N/A
Threads Started 0
Threads Started Percentage 0.00 %
Most Frequent Board N/A
Very First Post N/A
Percentage of Posts Rec'd 100.00 %
Show BiotechWilson’s 10 Latest Posts